Hepcidin as a potential biomarker for blood doping.

Détails

ID Serval
serval:BIB_014250D79895
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Hepcidin as a potential biomarker for blood doping.
Périodique
Drug testing and analysis
Auteur⸱e⸱s
Leuenberger N., Bulla E., Salamin O., Nicoli R., Robinson N., Baume N., Saugy M.
ISSN
1942-7611 (Electronic)
ISSN-L
1942-7603
Statut éditorial
Publié
Date de publication
07/2017
Peer-reviewed
Oui
Volume
9
Numéro
7
Pages
1093-1097
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: ppublish
Résumé
The concentration of hepcidin, a key regulator of iron metabolism, is suppressed during periods of increased erythropoietic activity. The present study obtained blood samples from 109 elite athletes and examined the correlations between hepcidin and markers of erythropoiesis and iron metabolism (i.e., haemoglobin, erythropoietin (EPO), ferritin, erythroferrone (ERFE), and iron concentration). Furthermore, an administration study was undertaken to examine the effect of recombinant human EPO (rhEPO) delta (Dynepo™) on hepcidin concentrations in healthy male volunteers. The effects on hepcidin were then compared with those on reticulocyte percentage (Ret%) and ferritin concentration. There was a significant positive correlation between hepcidin and ferritin, iron, and haemoglobin levels in athletes, whereas hepcidin showed an inverse correlation with ERFE. Administration of rhEPO delta reduced hepcidin levels, suggesting that monitoring hepcidin may increase the sensitivity of the Athlete Biological Passport (ABP) for detecting rhEPO abuse. Copyright © 2016 John Wiley & Sons, Ltd.

Mots-clé
EPO, blood doping, hepcidin
Pubmed
Web of science
Création de la notice
01/11/2016 19:34
Dernière modification de la notice
20/08/2019 12:23
Données d'usage